(Q37965397)

26 August 2017

0 references

Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype (English)

1 reference

26 August 2017

1 reference

1 reference

breast cancer surgery

1 reference

1 reference

Aoife J Lowery

1

1 reference

26 August 2017

Malcolm R Kell

2

1 reference

26 August 2017

Ronan W Glynn

3

1 reference

26 August 2017

Michael J Kerin

4

1 reference

26 August 2017

Karl J Sweeney

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

7 December 2011

1 reference

Breast Cancer Research and Treatment

26 August 2017

published in

1 reference

26 August 2017

volume

133

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

831-841

1 reference

Molecular portraits of human breast tumours

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

An overview of prognostic factors for long-term survivors of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Treatment and survival outcome for molecular breast cancer subtypes in black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Prognosis following local recurrence in the conservatively treated breast cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Triple-negative breast cancers: unique clinical presentations and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

Individual patient data meta-analysis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1891-6

10.1007/S10549-011-1891-6

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference